Your browser doesn't support javascript.
loading
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
Frank, Samuel; Testa, Claudia; Edmondson, Mary C; Goldstein, Jody; Kayson, Elise; Leavitt, Blair R; Oakes, David; O'Neill, Christine; Vaughan, Christina; Whaley, Jacquelyn; Gross, Nicholas; Gordon, Mark Forrest; Savola, Juha-Matti.
Afiliación
  • Frank S; Beth Israel Deaconess Medical Center/Harvard Medical School, 330 Brookline Ave, Kirstein 228, Boston, MA, 02215, USA. sfrank2@bidmc.harvard.edu.
  • Testa C; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Edmondson MC; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Goldstein J; Huntington Study Group, Rochester, NY, USA.
  • Kayson E; Huntington Study Group, Rochester, NY, USA.
  • Leavitt BR; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada.
  • Oakes D; University of Rochester, Rochester, NY, USA.
  • O'Neill C; Wake Forest University Baptist Medical Center, Winston Salem, NC, USA.
  • Vaughan C; University of Colorado, Denver, CO, USA.
  • Whaley J; Center for Health and Technology, University of Rochester, Rochester, NY, USA.
  • Gross N; Teva Pharmaceuticals, West Chester, PA, USA.
  • Gordon MF; Teva Pharmaceuticals, West Chester, PA, USA.
  • Savola JM; Teva Pharmaceuticals, Basel, Switzerland.
CNS Drugs ; 36(11): 1207-1216, 2022 11.
Article en En | MEDLINE | ID: mdl-36242718

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Corea / Enfermedad de Huntington Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: CNS Drugs Asunto de la revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Corea / Enfermedad de Huntington Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: CNS Drugs Asunto de la revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos